Pre-transplant pharmacokinetic profiling and tacrolimus requirements post-transplant.

Nephrology (Carlton, Vic.)

Volumn 15, Issue 7, 2010, Pages 714-719

  Campbell, Scott ^a   Hawley, Carmel ^b   Irish, Ashley ^b   Hutchison, Brian ^b   Walker, Rowan ^b   Butcher, Belinda E ^b   Ferrari, Paolo ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; AUSTRALIA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG COMBINATION; DRUG MONITORING; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AUSTRALIA; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; STEROIDS; TACROLIMUS;

MLCS; MLOWN;

EID: 79952276701     PISSN: None     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01351.x     Document Type: Article

References (0)